Behçet's disease is a systemic vasculitis frequently associated with intraocular inflammation.
Recent findings identified independent clinical clusters in Behçet's disease, each involving …

Uveitis is a group of diseases characterized by intraocular inflammation, of which some are
driven by autoinflammatory or autoimmune responses, such as Vogt-Koyanagi-Harada …

Abstract Purpose of Review To assess current management of Behcet's disease (BD).
Controversies on therapeutic approaches to different manifestations, whether conventional …

Introduction Behçet's disease (BD) is an auto-inflammatory disease, primarily characterized
by recurrent painful mucocutaneous ulcerations. Methods A literature search was performed …

Background Data from head-to-head trials of immunomodulatory therapies for Behçet's
disease are scarce. We aimed to compare the efficacy and safety of ciclosporin, interferon …

Uveitis is an inflammation of the iris, ciliary body, vitreous, retina, or choroid, which has been
shown to be the first manifestation of numerous systemic diseases. Studies about the …

Behcet's syndrome (BS) is a chronic systemic inflammatory vasculitis with a wide range of
clinical manifestations including recurrent oral and genital ulcers; cutaneous lesions; and …

Non-infectious uveitis (NIU) represents one of the leading causes of blindness in developed
countries. The therapeutic strategy aims to rapidly control intra-ocular inflammation, prevent …

Behçet disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology with the
clinical features of oral and genital ulcers, cutaneous vasculitic lesions, ocular, articular …

Objective Tocilizumab (TCZ) is the only biologic therapy approved for giant cell arteritis
(GCA). There is general agreement on the initial/maintenance dose, duration of TCZ therapy …